These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31081744)

  • 1. Hematotherapy.
    Mussolino C
    Stem Cells Dev; 2019 Jun; 28(11):714. PubMed ID: 31081744
    [No Abstract]   [Full Text] [Related]  

  • 2. The Potential of CRISPR/Cas9 in Hematotherapy.
    Bak RO
    Stem Cells Dev; 2019 Jun; 28(11):710-711. PubMed ID: 31090512
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 4. Base Editing: Efficient Installation of Point Mutations with Minimal Byproducts.
    Newby GA
    Stem Cells Dev; 2019 Jun; 28(11):712-713. PubMed ID: 31107171
    [No Abstract]   [Full Text] [Related]  

  • 5. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma.
    Hong L; Zhang C; Jiang Y; Liu H; Huang H; Guo D
    Future Oncol; 2020 Jun; 16(16):1125-1136. PubMed ID: 32338048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Take Risks and Constantly Challenge the Status Quo.
    Cong L
    Stem Cells Dev; 2019 Jun; 28(11):709. PubMed ID: 31090491
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene Therapy 2017: Progress and Future Directions.
    Keeler AM; ElMallah MK; Flotte TR
    Clin Transl Sci; 2017 Jul; 10(4):242-248. PubMed ID: 28383804
    [No Abstract]   [Full Text] [Related]  

  • 10. Huntington disease: Selective deactivation of Huntington disease mutant allele by CRISPR-Cas9 gene editing.
    Malkki H
    Nat Rev Neurol; 2016 Nov; 12(11):614-615. PubMed ID: 27686048
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas13a system: a novel approach to precision oncology.
    Zhang J; You Y
    Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
    [No Abstract]   [Full Text] [Related]  

  • 14. New Gene-Editing Tool Slowly Advances Into the Clinic.
    Jenks S
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
    [No Abstract]   [Full Text] [Related]  

  • 15. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
    Wang L; Zheng W; Liu S; Li B; Jiang X
    Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
    Baylis F
    Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
    Lin WV; Stout JT; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
    [No Abstract]   [Full Text] [Related]  

  • 18. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 19. A new era of gene editing for the treatment of human diseases.
    Kc M; Steer CJ
    Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing and Hematologic Malignancy.
    Emmer BT; Ginsburg D
    Annu Rev Med; 2020 Jan; 71():71-83. PubMed ID: 31469969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.